In the News

Share
460 News Items found
MSK physician Dr. Deb Schrag
Experimental Blood Test for Cancer Shows Potential To Screen for Multiple Types Simultaneously
Learn how a blood test could someday provide a way to detect cancers at an early stage.
MSK radiation oncologist Jonathan Yang, who specializes in treating metastatic cancer.
Proton Therapy for Leptomeningeal Metastasis Could Be a Major Advance
Learn how proton therapy can be an effective new treatment for leptomeningeal metastasis.
Dr. Sohrab Shah
Fighting Cancer With Computers, Math, and Artificial Intelligence
MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research.
Finding
Two chimpanzees in a field
Cancer Genes in Humans vs. Chimps: Why Are We More Susceptible?
In an unusual collaboration, scientists from MSK and the American Museum of Natural History looked at how the BRCA2 gene differs between humans and chimps. Mutations in this gene are linked to an increased risk of certain cancers, including breast cancer.
In the Lab
Adrienne Boire at the lab bench
Inspired by a Patient, a Doctor Finds Answers for a Devastating Cancer Complication
Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.
Feature
Pouring white wine into a glass
White Wine and Melanoma: Does Drinking Alcohol Increase Your Cancer Risk?
Hear from our experts about a new study linking alcohol consumption and melanoma risk.
MSK patient Marc Scarduffa seen holding his dog at the beach.
Clinical Trials at MSK Aim To Reduce Side Effects of Cancer Treatment
Learn how MSK is Improving patients’ quality of life with less toxic treatments.
Linda Collins, an MSK patient, posing for a photo outside
Why Black Women Are Twice as Likely to Die of Endometrial Cancer — and What MSK Is Doing to Change It
Learn why Black women face a higher risk of death from endometrial cancer, and about a new effort led by Dr. Carol Brown at Memorial Sloan Kettering Cancer Center to close the gap.
In the Lab
Christopher Klebanoff
New Immunotherapy Approach Targets a Commonly Mutated ‘Driver’ Protein Unique to Cancer Cells
Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer.
Andrea Barrio, a breast cancer surgeon at Memorial Sloan Kettering Cancer Center, talks to a patient
Important New Insights into Lymphedema: High Risk, Race, and Ethnicity
Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.